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3Adenosine is a locally produced mediator exerting several cytoprotective effects via G-protein 
coupled cell membrane adenosine receptors (ARs) (Linden 2005). In the skin, adenosine can 
influence several (patho)physiological processes, such as wound healing, development of 
scleroderma, cutaneous inflammation, allergic reactions or barrier formation (Andrés et al. 
2017; Burnstock et al. 2012; Silva-Vilches et al. 2019). A beneficial effect of adenosine on hair 
growth has already been reported in clinical studies: topical adenosine treatment was shown to 
alleviate the symptoms of alopecia by increasing hair thickness and promoting anagen hair 
growth (Iwabuchi et al. 2016; Oura et al. 2008; Watanabe et al. 2015); whereas adenosine also 
prolonged the anagen phase of mouse vibrissae cultures (Hwang et al. 2012). In parallel 
experiments, it upregulated the expression of fibroblast growth factor 7 (FGF-7) via activating 
A2B AR and stimulated the transcription of other growth factors in human dermal papilla (DP) 
cell cultures (Hwang et al. 2012; Iino et al. 2007). However, the influence of adenosine on the 
mechanisms of hair growth is not completely understood, and the role of ARs expressed in the 
different compartments of hair follicles (HFs) is not known in details. Therefore, we addressed 
the role of adenosine and ARs in hair cycle control studying isolated human HFs and primary 
outer root sheath (ORS) keratinocytes in vitro as described in the Supplementary methods.
First, we treated microdissected human HFs with adenosine administered in the culturing 
medium for several days and measured the length of the HFs on the 1st, 3rd and 5th days. We 
found that the hair shaft elongation was stimulated in the presence of 50 or 100 µM adenosine 
(Figure 1a). These concentrations of adenosine increased cellular proliferation in HFs, 
especially in the matrix keratinocytes of the hair bulb as indicated by the increased number of 
the cells positive for the proliferation associated antigen Ki67 (Supplementary figure 1a-b). In 
good accordance with the above, adenosine slightly shifted the hair cycle by prolonging the 
duration of the anagen phase and inhibiting catagen entry: the ratio of HFs in the anagen stage 
was higher when 100 µM adenosine was added to the culture medium for 6 days, as assessed 
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4by hair cycle staging based on the histomorphometric evaluation of the cultured HFs 
(Supplementary figure 1c-d). 
Next, we wanted to further challenge the anagen-promoting effect of adenosine by the 
co-administration of the catagen inducer transforming growth factor β2 (TGF-β2) (Langan et 
al. 2015). As expected, TGF-β2 significantly inhibited hair growth, decreased the proliferation 
and induced the apoptosis of hair matrix keratinocytes in cultured HFs (Figure 21b-d). TGF-β2 
also resulted in a striking catagen transition of the hair cycle and it practically abolished the 
anagen stage from the cultures in six days (Figure 21e-f, Supplementary Figure 2a-b). All these 
effects of TGF-β2 were mainly prevented by supporting the culture medium with 100 µM 
adenosine. Importantly, this blockade of TGF-β2 effect by adenosine was abrogated by the co-
application of CGS15943, a pan-antagonist of ARs.
Therefore, we investigated the presence of ARs in human HFs. We isolated total mRNA 
from anagen human HFs from 3 donors, and determined the expression of ARs A1, A2A, A2B 
and A3 by Q-PCR following reverse transcription. We found that the transcripts of all four 
investigated receptors are expressed in HFs (Figure 2a) among which A2B was found to be the 
dominant isoform: its expression was at least 1 magnitude higher than any other isoform in the 
tested donors.
We studied the localization of AR proteins within the HF applying immunofluorescent 
labelling on frozen sections of isolated human anagen HFs (Figure 2b) using specific antibodies 
against ARs (Supplementary Figure 3). A1 showed a diffuse expression overall in the matrix 
and ORS keratinocytes, whereas A2A and A2B isoforms were highly expressed in the ORS and 
some cells in the dermal papilla in line with the previous results of Iino et al (2017) who 
investigated the expression of A2B in human scalp specimen and dermal papilla cells. The 
surrounding connective tissue sheath (CTS) was also positive for A2B and some A2A was also 
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5detected in the inner root sheath (IRS). A3 was detected primarily in matrix keratinocytes above 
the Auber’s line, and a weak signal was observed in the ORS. 
We isolated keratinocytes from the ORS, since immunofluorescence detected all ARs in 
that compartment and further studied the expression of ARs in the isolated cells. Q-PCR and 
immunofluorescent staining confirmed our results obtained in HF cultures: even in monolayer 
cultures, ORS keratinocytes expressed all four ARs, (Figure 2c-d.). Similar to HFs, the 
expression of the A2B transcripts was found to be higher than the expression of the other 
isoforms with the marked dominance of the A2B isoform (Figure 2c-d).
In our final experiments, we further dissected the potential mechanisms of adenosine on 
hair growth and the hair cycle. Since the ORS is well-known to synthesize both positive and 
negative paracrine regulators of hair growth and the hair cycle [e.g. TGF-β2, insulin like growth 
factor 1 (IGF-1) or stem cell factor/c-kit ligand (SCF), etc. (Bodó et al. 2005; Langan et al. 
2015; Paus et al. 2014; Soma et al. 2002; Stenn and Paus 2001; Szabó et al. 2018)], we studied 
the effect of adenosine on the expression of selected, well established hair cycle regulators in 
ORS keratinocytes isolated from 3 donors. Detecting the specific mRNA transcripts, we found 
that adenosine downregulated the expression of the catagen inducing mediators TGF-β2 and 
epidermal growth factor. In contrast, expression of the anagen and pigmentation promoting 
mediator SCF was upregulated by adenosine treatment, as well as the expression of insulin like 
growth factor-1 receptor (IGF-1R) (Figure 2e). These alterations in gene expression induced by 
adenosine were observable in the samples of each donor. Importantly, the effect of adenosine 
was blocked by both the general AR receptor antagonist CGS15943 and MRS1754, an A2B 
selective inhibitor, in case of each donor although the magnitude of the responses was variable 
among donors tested. These data demonstrated convincingly that adenosine can control the hair 
cycle via ARs expressed in human HFs. Moreover, our results also suggest that adenosine can 
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6regulate complex intercellular signaling pathways in HFs acting on ARs (especially A2B) 
expressed by ORS keratinocytes beyond previously described dermal papilla cells. 
Our findings describe the growth and anagen promoting effect of adenosine via ARs in 
human HFs and identify especially A2B expressed in ORS keratinocytes as a promising 
pharmacological target to influence various hair growth disorders, such as various forms 
alopecia.
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FIGURE LEGENDS
Figure 1. Adenosine enhanced HF elongation and prevented the hair growth-inhibiting 
and catagen-inducing effect of TGF-β2. (a) and (b) HF elongation curves. HFs were treated 
with vehicle (control) or with adenosine, TGF-β2, and adenosine receptor antagonist 
CGS15943 in combinations as indicated in the figure. Mean±SEM of N=36 (a) or N=28-29 (b) 
HFs/group from three individual donors. (c) Co-immunolabeling of proliferating (Ki-67+, red) 
and apoptotic (TUNEL+, green) cells along with nuclear staining (DAPI, blue). Representative 
images demonstrating the effect of the compounds indicated. (d) Statistical analysis of co-
immunolabeled proliferating (Ki-67+) and apoptotic (TUNEL+) cells, following treatments 
with the indicated compounds applied in the same concentration as in panel (b) for 6 days. 
Percentage of total cell number (DAPI+ nuclei). N=16-24 HFs of 3 donors/group. (e) 
Representative hematoxylin eosin-stainings showing the effect of the indicated compounds on 
the morphology of HFs. (f) Percentage of organ cultured HFs in anagen and catagen stages as 
determined by quantitative hair cycle histomorphometry based on hematoxylin eosin-stained 
sections. N=17-24 HFs/group from three different donors. *p<0.05, **p<0.01 and ***p<0.001 
compared to control, #p<0.05, ##p<0.01 and ###p<0.001 compared to TGF-β2 treated group and 
$p<0.05, $$p<0.01 and $$$p<0.001 compared to TGF-β2 and adenosine treated group as 
determined by One-way ANOVA and Dunnett (a) or Bonferroni post hoc tests (b) and (d), or 
compering the distribution of HFs in the different hair cycle stages pairwise by Fisher’s exact 
test (c). Scale bars:50 µm.
Figure 2. Adenosine Receptors (ARs) expressed in isolated human hair follicles (HFs) and 
cultured outer root sheath (ORS) keratinocytes controlled the expression of negative and 
positive hair cycle regulators in isolated ORS keratinocytes. (a) Expression of ARs’ 
transcripts in human HFs of three donors as assessed by Q-PCR. Data are expressed as 
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mean±SEM of three independent determinations. Data are normalized to the expression of 
cyclophilin A (PPIA) determined as endogenous control. (b) Immunofluorescent staining 
(FITC, green fluorescence) of ARs in organ-cultured human HFs. Nuclei were counterstained 
with 4’,6-diamidino-2’-phenylindole (DAPI, blue fluorescence). Scale bars represent 50 µm. 
DP, dermal papilla; MK, matrix keratinocytes; ORS, outer root sheath. Inset: negative control 
(NC). (c) Expression of ARs’ transcripts in cultured ORS keratinocytes determined by Q- PCR 
as on panel (a). (d) Immunofluorescent staining (FITC, green fluorescence) of ARs in cultured 
human ORS keratinocytes. Scale bars represent 10 µm. Inset: negative control (NC). (e) ORS 
keratinocytes were isolated from 3 individual donors and cultured in the presence of 100 µM 
adenosine and adenosine receptor antagonist CGS15943 (CGS, 100 nM) or A2B selective 
blocker MRS1754 (MRS, 10 nM) as indicated for 3 hrs. Relative gene expression was 
determined and normalized to the expression values of the vehicle-treated (i.e. adenosine and 
inhibitor free) samples counted as 1 in each individual donor. Values of individual donors are 
presented as mean±SEM of three independent determinations. As endogenous control, the 
expression of PPIA was determined.
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 Figure 1: Adenosine enhanced HF elongation and prevented the hair growth-inhibiting and catagen-inducing 
effect of TGF-β2 
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 Figure 2: Adenosine Receptors (ARs) expressed in isolated human hair follicles (HFs) and cultured outer root 
sheath (ORS) keratinocytes controlled the expression of negative and positive hair cycle regulators in 
isolated ORS keratinocytes. 
199x299mm (300 x 300 DPI) 
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2SUPPLEMENTARY METHODS
Isolation and Maintenance of Hair Follicles (HFs):
Human skin samples were obtained from healthy individuals undergoing neurosurgery 
with written informed consent, adhering to Helsinki guidelines, and after obtaining the 
permission of the Institutional Research Ethics Committee’s and the Government Office for 
Hajdú-Bihar County (protocol No.: DE OEC RKEB/IKEB 3724-2012; document IDs: IX-R-
052/01396-2/2012, IF-12817/2015, IF-1647/2016, IF-778-5/2017). Human anagen VI HFs 
were isolated from the skin of male donors and maintained, as we have described before (Bodó 
et al. 2005; Telek et al. 2007; Bodó et al. 2009; Ramot et al. 2010; Borbíró et al. 2011; Szabó 
et al. 2018; Oláh et al. 2016). Briefly, isolated HFs were collected and maintained in Williams’ 
E medium (Life Technologies Corporation, Foster City, CA, USA) supplemented with 2 mM 
L-glutamine (Life Technologies), 10 ng/ml hydrocortisone, 10 mg/ml insulin, and antibiotics 
(all from Sigma- Aldrich, St. Louis, MO, USA). Culture medium was changed every other day, 
whereas treatment with various compounds was performed daily. For immunofluorescent 
staining and histomorphometry, follicles were frozen at -80 °C and further processed after 6 
days in culture.
Culturing of Human HF-derived Outer Root Sheath Keratinocytes
Plucked human scalp HFs of several male volunteers were digested using trypsin to obtain 
outer root sheath (ORS) keratinocytes (Ramot et al. 2018). Similarly, human dermal fibroblasts 
(HDFs) were obtained from de-epidermized dermis of human skin samples using enzymatic 
digestion. ORS keratinocyte cultures were kept on feeder layer of non-proliferating HDFs 
treated with mitomycin C (Sigma-Aldrich) in a 1:3 mixture of supplemented Ham’s F12 and 
Dulbecco’s modified Eagle’s medium (both from Life Technologies) supplemented with 10% 
Fetal Clone II (HyClone, South Logan, UT, USA), 0.1 nM cholera toxin, 5 μg/ml insulin, 0.4 
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3μg/ml hydrocortisone, 2.43 μg/ml adenine, 2 nM triiodothyronine, 10 ng/ml epidermal growth 
factor, 1 mM ascorbyl-2-phosphate and antibiotics (all from Sigma-Aldrich) as described 
previously (Bodó et al. 2005; Borbíró et al. 2011; Ramot et al. 2018; Szabó et al. 2018; Telek 
et al. 2007).
Before experiments, ORS keratinocytes were harvested, and re-plated without a HDF 
feeder layer in 6-well plates (200,000 cells/well) which were previously coated with 1% 
collagen (Sigma Aldrich) and kept in serum-free medium for 24 hours before treating them with 
different compounds. 3 hours after treatment cells were harvested using TRIzol (Life 
Technologies) and then RT-qPCR were performed as described below. 
Measurement of Hair Shaft Elongation
Length measurements on individual cultured HFs were performed using a light 
microscope with an eyepiece measuring graticule. Elongation was calculated for each hair 
follicle separately, by subtracting the length measured on day 0 from the value of the relevant 
day.
Quantitative “Real-Time” PCR 
Total RNA was isolated using TRIzol reagent (Life Technologies) and digested with 
recombinant RNase-free DNase-1 (Life Technologies) according to the manufacturer’s 
protocol. After isolation, 1 μg of total RNA was reverse-transcribed into cDNA using the High 
Capacity cDNA kit (Life Technologies) following the manufacturer’s instructions. 
Quantitative real-time PCR was performed on a Stratagene Mx3005p sequence detection 
system (Agilent Technologies Inc., Santa Clara, CA, USA) by using 5’ nuclease assay. PCR 
amplification was performed using specific TaqMan primers and probes as follows; for 
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4adenosine A1 receptor (ADORA1, Assay ID: Hs00379752_m1); for adenosine A2A receptor 
(ADORA2A, Assay ID: Hs00169123_m1); for adenosine A2B receptor (ADORA2B, Assay ID: 
Hs00386497_m1); for adenosine A3 receptor (ADORA3, Assay ID: Hs00252933_m1); for 
transforming growth factor beta 2 (TGFB2, Assay ID: Hs00234244_m1); for epidermal growth 
factor (EGF, Assay ID: Hs01099999_m1); for stem cell factor (SCF/KITLG, assay ID: 
Hs00241497_m1) and for insulin-like growth factor 1 receptor (IGF1R, Assay ID: 
Hs00609566_m1) using the TaqMan Gene Expression Master Mix Protocol (Life 
Technologies). As internal control, transcripts of cyclophilin A (PPIA, Assay ID: 
Hs99999904_m1) were determined. The amount of the above mentioned transcripts was 
normalized to the expression of the internal control gene, using the ΔCt method. Briefly: the 
threshold cycle (Ct) value of the target gene was subtracted from the average Ct value of the 
control gene resulting in the ΔCt value. ΔCt was then used as a power of two, which results in 
the relative expression of a given target gene compared to the control (i.e.: 2ΔCt). All 
experiments were performed in triplicates. 
Immunolabeling of ARs
To detect the four type of ARs on isolated HFs and ORS keratinocytes, we performed 
indirect fluorescent immunolabeling. Cryosections of isolated HFs fixed with ice-cold 
ethanol:acetic acid (2:1) or acetone-fixed ORS keratinocytes grown on coverslips were first 
incubated with different primary rabbit antibodies (1:100 in DCS antibody diluent [DCS 
Innovative Diagnostik-Systeme, Hamburg, Germany] overnight, 4 °C) against A1, A2A (Abcam, 
Cambridge, UK, cat. numbers: ab124780 and ab3461, respectively), A2B and A3 (Alomone 
Labs, Jerusalem, Israel, cat. numbers: AAR-003 and AAR-004, respectively) receptors. 
Sections and coverslips were then washed with phosphate-buffered saline (PBS), followed by 
incubation with Alexa Fluor 488 dye-conjugated goat anti-rabbit IgG (Life Technologies) 
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5(1:500 in DCS antibody diluent, 45 min) at room temperature according to standard procedures. 
Nuclei were counterstained with 4’,-6-diamidino-2-phenylindole (DAPI) (Life Technologies) 
(1 µg/ml in distilled water, 5 min), and sections were mounted with Fluoromount-G aqueous 
medium (Southern Biotech, Birmingham, USA). Images were acquired using an Eclipse E600 
fluorescent microscope (Nikon, Tokyo, Japan). To verify the specificity of the antibodies used, 
paraffin embedded routine histology sections from tissues known to express different ARs were 
stained as positive controls. Human cerebral cortex served as positive control for A1 and A2A 
(Latini et al. 1996; Luan et al. 2017; Svenningsson et al. 1997), human kidney for A2B (Zhang 
et al. 2013) and human cerebellum for A3 (Haeusler et al. 2015). Following deparaffination and 
antigen retrieval (in citrate-buffer, pH 6.0, at 750 W in microwave oven for 15 min), sections 
were incubated with the above primary rabbit antibodies against human ARs, then stained with 
HRP conjugated anti-rabbit IgG (1:500) (Bio-Rad, Hercules, CA, USA). Immunoreactions 
were visualized using DAB substrate kit (Vector Labs, Burlingame, California USA) and the 
sections were counterstained by hematoxylin (Sigma-Aldrich). For all immunostainings, the 
respective primary antibodies were omitted as negative controls.
Ki-67/TUNEL Double Labeling
To simultaneously detect proliferating and apoptotic cells in the HFs, Ki-67 
immunolabeling and terminal dUTP nick end labeling (TUNEL) were performed in a double-
staining protocol, respectively (Bodó et al. 2005; Borbíró et al. 2011; Langan et al. 2015; Purba 
et al. 2016; Szabó et al. 2018; Telek et al. 2007). Cryosections were fixed in 
formalin/ethanol/acetic acid and labeled with a digoxigenin-deoxyUTP (ApopTag Fluorescein 
In Situ Apoptosis detection kit; Millipore, Billerica, MA) in presence of terminal 
deoxynucleotidyl transferase (60 min, 4 °C) according to the manufacturers protocol, followed 
by overnight incubation with a mouse anti-Ki-67 antiserum (1:20, DAKO, Carpinteria, CA) at 
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64 °C. TUNEL+ cells were visualized by an anti-digoxigenin FITC-conjugated antibody 
(ApopTag kit), whereas Ki-67 was detected by an Alexa Fluor 568 dye-conjugated secondary 
antibody (Life Technologies, 1:500 at 4 °C for 45 min). Negative control stainings were 
performed by omitting terminal deoxynucleotidyl transferase and the Ki-67 antibody (data not 
shown). Cells positive for Ki-67 or TUNEL were counted per hair bulb (under the cross-
sectional line perpendicular for the longitudinal axis of the hair shaft and tangential to the peak 
of the dermal papilla) and were normalized to the number of nuclei (DAPI+).
Histology and Quantitative Histomorphometry
Cryosections (6 µm) of cultured HFs were fixed in acetone, air-dried, and processed for 
routine histology. Hematoxylin and eosin (HE, Sigma-Aldrich) staining was used for studying 
HF morphology and hair cycle stage (anagen and different stages of catagen) of each HF was 
assessed according to defined morphological criteria (Kloepper et al. 2010; Langan et al. 2015).
Additionally, number of DAPI+ cells in a standardized area of the dermal papilla (DP) 
stalk was counted on Ki-67/TUNEL double labeled sections to further characterize hair cycle 
quantitatively (Kloepper et al. 2010).
Statistical Analysis
If not mentioned otherwise, values are presented as mean±SEM in every group. To 
compare the mean values of multiple groups, statistical analysis was subsequently performed 
by One-way ANOVA and Dunnett or Bonferroni post hoc tests, as appropriate. Significance 
was determined as *p<0.05, **p<0.01, ***p<0.001 compared to the control and/or $ or #p<0.05, 
$$ or ##p<0.01, $$$ or ###p<0.001 compared to different treated samples as indicated. Differences 
in distribution of HFs among different hair cycle stages was compared pairwise by Fisher’s 
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7exact test. Origin 9.0 (OriginLab Corporation, Northampton MA, USA) and IBM SPSS 
Statistics 23.0 (IBM Corporation. Armonk, NY, USA) were used to plot the data and perform 
statistical analysis, respectively. 
Materials
Adenosine, CGS15943 (non-selective AR antagonist), MRS1754 (selective A2B 
antagonist) and TGF-β2 were obtained from Sigma-Aldrich.
DATA AVAILABILITY STATEMENT
Datasets related to this article are freely available upon request. Requests should be addressed 
to the corresponding author.
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8SUPPLEMENTARY TEXT: DISCUSSION OF THE POTENTIAL MOLECULAR 
MECHANISMS UNDERLYING THE REGULATION OF HAIR GROWTH BY 
ADENOSINE
The favorable action of adenosine is supported by a growing body of evidence in HF 
biology but the potential mechanism of action has not been resolved yet. To get deeper insight 
into the cellular and molecular mechanisms of how adenosine can enhance human hair growth, 
we studied the effect of adenosine in an in vitro model of human hair growth using 
microdissected and organ cultured human HFs (Langan et al. 2015; Philpott et al. 1994). In 
good accordance with the previous clinical findings, we quantitatively measured that adenosine 
enhanced the hair shaft elongation in human HF cultures isolated from Caucasian male subjects 
in vitro. As a potential underlying mechanism, we found increased intrafollicular proliferation 
and also observed that the ratio of HFs in catagen stage was decreased and more HFs showed 
morphological signs characteristic for the growing anagen phase in the adenosine treated 
cultures. These results suggested that adenosine may have a regulatory effect on hair cycle. To 
explore how adenosine can influence the hair cycle, we induced the onset of the regressive 
catagen phase by adding TGF-β2 to the culture medium. Adenosine abolished the effects of 
TGF-β2: it prevented diminished hair growth, it reversed reduced intrafollicular proliferation 
and augmented apoptosis induced by TGF-β2, as well as inhibited catagen transition and kept 
the anagen morphology of the HFs. These findings strongly support that adenosine can have a 
significant impact on hair cycle regulation. Importantly, all the above effects of adenosine were 
inhibited by the general AR antagonist CGS15943 arguing for the specific role of adenosine 
related signaling in the hair growth control.
A complex molecular interaction between mesenchymal and epithelial cells of the HFs, 
e.g. dermal papilla cells and keratinocytes of the different layers, plays a crucial role in the 
regulation of hair cycle (Schneider et al. 2009; Stenn and Paus 2001). Although Wnt/β-catenin 
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9signaling and several additional factors regulating the transition between the individual phases 
are relatively well-documented in the literature, the exact origin of the cyclic program and all 
the molecular details of the intercellular interactions are not resolved as of yet (Bernard 2012). 
Earlier studies identified several positive regulator molecules of the hair cycle which promote 
hair growth and prolong anagen phase of hair follicle cultures or upregulate melanogenesis 
linked to anagen phase, e.g. β-catenin, IGF-I, fibroblast growth factor 7/keratinocyte growth 
factor (FGF7/KGF) or stem cell factor/KIT-ligand (SCF). On the other hand, negative hair cycle 
regulators like epidermal growth factor (EGF), TGF-β1, FGF5, and interferon gamma can 
initiate catagen transition and inhibit hair shaft elongation in vitro. Importantly, the expression 
of these regulatory molecules and their receptors are widely documented in various 
mesenchymal and epithelial components of the HFs providing an extended paracrine regulatory 
network for hair cycle and growth control (Langan et al. 2015; Paus et al. 2014; Stenn and Paus 
2001). The modulation of these paracrine mechanisms regulating the hair cycle may be an 
effective tool to influence hair growth. For example, activation of β-catenin signaling activated 
a telogen to anagen transition and induced intense growth and intrafollicular proliferation of the 
epithelial components in HFs (Choi et al. 2013; Van Mater et al. 2003). Importantly, an intimate 
relationship is suggested between adenosine and Wnt/β-catenin signaling in the skin. It was 
shown that A2A promotes collagen type III synthesis via β-catenin activation in human dermal 
fibroblasts (Shaikh et al. 2016) and pharmacological blockade of A2A diminished the activity 
of Wnt/β-catenin pathway in a bleomycin-induced dermal fibrosis mouse model (Zhang et al. 
2017). Moreover, Wnt/β-catenin signaling can promote extracellular adenosine generation via 
upregulating ecto-5'-nucleotidase and downregulating adenosine deaminase in Rat-1 cell line 
(Spychala and Kitajewski 2004). These data suggest that Wnt/β-catenin pathway can be a 
downstream target of adenosine receptor signalling as well as can act as a regulator of adenosine 
production i.e upstream of adenosine receptors. Moreover, in recent studies, adenosine was 
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reported to increase the expression of FGF2, FGF7, IGF1 and VEGF in cultured dermal papilla 
fibroblasts (Hwang et al. 2012). In human dermal papilla cell cultures, the upregulation of FGF7 
by adenosine was abolished in the presence of the A2B antagonist alloxazine. In good 
accordance, A2B receptors were also detected by immunohistochemistry in the dermal papilla 
and outer root sheath of human hair follicles (Iino et al. 2007). In our study, we detected all AR 
subtypes in human cultured HFs. Importantly, our quantitative gene expression data also 
verified the A2B as the dominantly expressed AR in the HF. The expression pattern was similar 
to that found by Iino et al. (Iino et al. 2007): beyond the dermal papilla, the outer root sheath 
showed strong positivity for A2B receptors. This high expression was maintained in isolated 
outer root sheath keratinocytes in vitro, as well.
Treating the ORS keratinocyte cultures with adenosine, we revealed a marked alteration 
in the expression of hair cycle regulating factors: the receptor of the positive hair cycle regulator 
IGF1 and the anagen related pigmentation promoting SCF were upregulated, but the strong 
catagen inducer TGF-β2 and EGF were downregulated. These results suggest that the anagen 
and hair growth promoting effect of adenosine, next to the previously suggested dermal papilla 
cells, may be mediated by the outer root sheath, as well. These results suggest that adenosine 
can generally affect both sides of the local mesenchymal-epithelial paracrine communication 
in the HF.
Importantly, HFs seems not to be only “passive” targets of adenosine, but might produce 
adenosine locally, although this likely assumption still requires further experimental support. 
However, earlier results suggested that a local, intrafollicular adenosine system can mediate the 
effect of hair growth promoting drugs. Minoxidil, a well-known hair growth promoting 
compound generally used to treat alopecia (Goren and Naccarato 2018), was shown to increase 
VEGF production in dermal papilla cells which effect was mimicked by adenosine and 
attenuated by inhibitors of A1 and A2 receptors expressed by dermal papilla cells suggesting 
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that local adenosine production mediates the beneficial effect of minoxidil on hair growth (Li 
et al. 2001). Although the mechanism of the local adenosine production is not known yet, a 
recent study reported expression of connexin and pannexin channels in the keratinocytes of the 
hair follicles (Cowan et al. 2012) which channels are known to release ATP (Lazarowski 2012), 
the precursor of extracellular adenosine synthesis by ectonucelotidases ecto-apyrase (CD39) 
and ecto-5’-nucleotidase (CD73) (Zimmermann 2000). 
Although the detailed description of the intrafollicular adenosine system needs further 
studies, our results provide a deeper insight into the mechanisms on how adenosine can promote 
hair growth via increased intrafollicular proliferation and inhibition of catagen transition. 
Moreover, our findings highlighted the potential role of outer root sheath keratinocytes and 
their adenosine receptors as a target of exogenously applied or endogenously produced 
adenosine. These results underline the role of the intrafollicular adenosine signaling as a 
potential therapeutic target to treat hair loss-associated diseases.
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SUPPLEMENTARY FIGURE LEGENDS
Supplementary Figure 1. Adenosine enhanced intrafollicular proliferation and prolonged 
anagen phase in human HF organ cultures. (a) Co-immunolabeling of proliferating (Ki67+, 
red) and apoptotic (TUNEL+, green) cells along with nuclear staining (DAPI, blue). Auber’s 
line is indicated through the bulbs. Scale bars represent 50 µm. (b) Mean ratio of Ki67+ cells 
as percentage of the total cell count (DAPI+ cells) in the bulb, N=25-31 HFs/group from three 
donors, *p<0.05, between the indicated groups by One-way ANOVA and Bonfferroni post hoc 
test. (c) Representative histological (hematoxylin-eosin) images illustrating the morphological 
changes (d) Percentage of organ cultured HFs in anagen and catagen stages as determined by 
quantitative hair cycle histomorphometry based on hematoxylin eosin-stained sections. N=25-
31 HFs/group from three donors. 
Supplementary Figure 2. Adenosine prevents the effect of TGFβ2 as demonstrated by the 
decrease of  the number of cells in the DP stalk, a quantitative marker of hair cycle-
staging. (a) Representative images illustrating the region in which the number of DAPI+ nuclei 
were analyzed. In catagen stage, more DAPI+ cells migrate to the DP stalk. (b) Quantitative 
analysis on the number of cells in the DP stalk. N=17-24 HFs/group, **p<0.01 and ***p<0.001 
comparing the indicated groups as determined by One-way ANOVA and Bonferroni post hoc 
tests (b).
Supplementary Figure 3. Specificity of the antibodies used to detect human ARs via 
immunolabaling. Various tissues described in the cited literature as expressing ARs were 
labeled with the primary antibodies used to stain ARs in HFs and ORS keratinocytes. (a) A1 
stained in human cerebral cortex. Pyr.c.,: Pyramidal cell (b) A2a stained in human cerebral 
cortex. (c) A2b stained in human kidney. gl.: glomerulus, PCT: proximal tubule, DCT: distal 
tubule. (d) A3 stained in human cerebellar cortex. mol.lay.: molecular layer, gr.lay.: granular 
layer,  Pur.c.: Purkinje cell. NC: negative control.
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3Adenosine is a locally produced mediator exerting several cytoprotective effects via G-protein 
coupled cell membrane adenosine receptors (ARs) (Linden 2005). In the skin, adenosine can 
influence several (patho)physiological processes, such as wound healing, development of 
scleroderma, cutaneous inflammation, allergic reactions or barrier formation (Andrés et al. 
2017; Burnstock et al. 2012; Silva-Vilches et al. 2019). A beneficial effect of adenosine on hair 
growth has already been reported in clinical studies: topical adenosine treatment was shown to 
alleviate the symptoms of alopecia by increasing hair thickness and promoting anagen hair 
growth (Iwabuchi et al. 2016; Oura et al. 2008; Watanabe et al. 2015); whereas adenosine also 
prolonged the anagen phase of mouse vibrissae cultures (Hwang et al. 2012). In parallel 
experiments, it upregulated the expression of fibroblast growth factor 7 (FGF-7) via activating 
A2B AR and stimulated the transcription of other growth factors in human dermal papilla (DP) 
cell cultures (Hwang et al. 2012; Iino et al. 2007). However, the influence of adenosine on the 
mechanisms of hair growth is not completely understood, and the role of ARs expressed in the 
different compartments of hair follicles (HFs) is not known in details. Therefore, we addressed 
the role of adenosine and ARs in hair cycle control studying isolated human HFs and primary 
outer root sheath (ORS) keratinocytes in vitro as described in the Supplementary methods. 
Human HFs were isolated from human skin samples obtained from healthy individuals 
undergoing neurosurgery with written informed consent, adhering to Helsinki guidelines, and 
after obtaining the permission of the Institutional Research Ethics Committee’s and the 
Government Office for Hajdú-Bihar County (protocol No.: DE OEC RKEB/IKEB 3724-2012; 
document IDs: IX-R-052/01396-2/2012, IF-12817/2015, IF-1647/2016, IF-778-5/2017).
First, we treated microdissected human HFs with adenosine administered in the culturing 
medium for several days and measured the length of the HFs on the 1st, 3rd and 5th days. We 
found that the hair shaft elongation was stimulated in the presence of 50 or 100 µM adenosine 
(Figure 1a). These concentrations of adenosine increased cellular proliferation in HFs, 
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4especially in the matrix keratinocytes of the hair bulb as indicated by the increased number of 
the cells positive for the proliferation associated antigen Ki67 (Supplementary figure 1a-b). In 
good accordance with the above, adenosine slightly shifted the hair cycle by prolonging the 
duration of the anagen phase and inhibiting catagen entry: the ratio of HFs in the anagen stage 
was higher when 100 µM adenosine was added to the culture medium for 6 days, as assessed 
by hair cycle staging based on the histomorphometric evaluation of the cultured HFs 
(Supplementary figure 1c-d). 
Next, we wanted to further challenge the anagen-promoting effect of adenosine by the 
co-administration of the catagen inducer transforming growth factor β2 (TGF-β2) (Langan et 
al. 2015). As expected, TGF-β2 significantly inhibited hair growth, decreased the proliferation 
and induced the apoptosis of hair matrix keratinocytes in cultured HFs (Figure 1b-d). TGF-β2 
also resulted in a striking catagen transition of the hair cycle and it practically abolished the 
anagen stage from the cultures in six days (Figure 1e-f, Supplementary Figure 2a-b). All these 
effects of TGF-β2 were mainly prevented by supporting the culture medium with 100 µM 
adenosine. Importantly, this blockade of TGF-β2 effect by adenosine was abrogated by the co-
application of CGS15943, a pan-antagonist of ARs.
Therefore, we investigated the presence of ARs in human HFs. We isolated total mRNA 
from anagen human HFs from 3 donors, and determined the expression of ARs A1, A2A, A2B 
and A3 by Q-PCR following reverse transcription. We found that the transcripts of all four 
investigated receptors are expressed in HFs (Figure 2a) among which A2B was found to be the 
dominant isoform: its expression was at least 1 magnitude higher than any other isoform in the 
tested donors.
We studied the localization of AR proteins within the HF applying immunofluorescent 
labelling on frozen sections of isolated human anagen HFs (Figure 2b) using specific antibodies 
against ARs (Supplementary Figure 3). A1 showed a diffuse expression overall in the matrix 
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5and ORS keratinocytes, whereas A2A and A2B isoforms were expressed in the ORS and some 
cells in the dermal papilla in line with the previous results of Iino et al (2017) who investigated 
the expression of A2B in human scalp specimen and dermal papilla cells. The surrounding 
connective tissue sheath (CTS) was also positive for A2B and some A2A was also detected in the 
inner root sheath (IRS). A3 was detected primarily in matrix keratinocytes above the Auber’s 
line, and a weak signal was observed in the ORS. 
We isolated keratinocytes from the ORS, since immunofluorescence detected all ARs in 
that compartment and further studied the expression of ARs in the isolated cells. Q-PCR and 
immunofluorescent staining confirmed our results obtained in HF cultures: even in monolayer 
cultures, ORS keratinocytes expressed all four ARs (Figure 2c-d.). Similar to HFs, the 
expression of the A2B transcripts was found to be higher than the expression of the other 
isoforms (Figure 2c).
In our final experiments, we further dissected the potential mechanisms of adenosine on 
hair growth and the hair cycle. Since the ORS is well-known to synthesize both positive and 
negative paracrine regulators of hair growth and the hair cycle [e.g. TGF-β2, insulin like growth 
factor 1 (IGF-1) or stem cell factor/c-kit ligand (SCF), etc. (Bodó et al. 2005; Langan et al. 
2015; Paus et al. 2014; Soma et al. 2002; Stenn and Paus 2001; Szabó et al. 2018)], we studied 
the effect of adenosine on the expression of selected, well established hair cycle regulators in 
ORS keratinocytes isolated from 3 donors. Detecting the specific mRNA transcripts, we found 
that adenosine downregulated the expression of the catagen inducing mediators TGF-β2 and 
epidermal growth factor. In contrast, expression of the anagen and pigmentation promoting 
mediator SCF was upregulated by adenosine treatment, as well as the expression of insulin like 
growth factor-1 receptor (IGF-1R) (Figure 2e). These alterations in gene expression induced by 
adenosine were observable in the samples of each donor. Importantly, the effect of adenosine 
was blocked by both the general AR receptor antagonist CGS15943 and MRS1754, an A2B 
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6selective inhibitor, in case of each donor although the magnitude of the responses was variable 
among donors tested. These data demonstrated convincingly that adenosine can control the hair 
cycle via ARs expressed in human HFs. Moreover, our results also suggest that adenosine can 
regulate complex intercellular signaling pathways in HFs acting on ARs (especially A2B) 
expressed by ORS keratinocytes beyond previously described dermal papilla cells. 
Our findings describe the growth and anagen promoting effect of adenosine via ARs in 
human HFs and identify especially A2B expressed in ORS keratinocytes as a promising 
pharmacological target to influence various hair growth disorders, such as various forms 
alopecia.
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FIGURE LEGENDS
Figure 1. Adenosine enhanced HF elongation and prevented the hair growth-inhibiting 
and catagen-inducing effect of TGF-β2. (a) and (b) HF elongation curves. HFs were treated 
with vehicle (control) or with adenosine, TGF-β2, and adenosine receptor antagonist 
CGS15943 in combinations as indicated in the figure. Mean±SEM of N=36 (a) or N=28-29 (b) 
HFs/group from three individual donors. (c) Co-immunolabeling of proliferating (Ki-67+, red) 
and apoptotic (TUNEL+, green) cells along with nuclear staining (DAPI, blue). Representative 
images demonstrating the effect of the compounds indicated. (d) Statistical analysis of co-
immunolabeled proliferating (Ki-67+) and apoptotic (TUNEL+) cells, following treatments 
with the indicated compounds applied in the same concentration as in panel (b) for 6 days. 
Percentage of total cell number (DAPI+ nuclei). N=16-24 HFs of 3 donors/group. (e) 
Representative hematoxylin eosin-stainings showing the effect of the indicated compounds on 
the morphology of HFs. (f) Percentage of organ cultured HFs in anagen and catagen stages as 
determined by quantitative hair cycle histomorphometry based on hematoxylin eosin-stained 
sections. N=17-24 HFs/group from three different donors. *p<0.05, **p<0.01 and ***p<0.001 
compared to control, #p<0.05, ##p<0.01 and ###p<0.001 compared to TGF-β2 treated group and 
$p<0.05, $$p<0.01 and $$$p<0.001 compared to TGF-β2 and adenosine treated group as 
determined by One-way ANOVA and Dunnett (a) or Bonferroni post hoc tests (b) and (d), or 
compering the distribution of HFs in the different hair cycle stages pairwise by Fisher’s exact 
test (c). Scale bars:50 µm.
Figure 2. Adenosine Receptors (ARs) expressed in isolated human hair follicles (HFs) and 
cultured outer root sheath (ORS) keratinocytes controlled the expression of negative and 
positive hair cycle regulators in isolated ORS keratinocytes. (a) Expression of ARs’ 
transcripts in human HFs of three donors as assessed by Q-PCR. Data are expressed as 
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mean±SEM of three independent determinations. Data are normalized to the expression of 
cyclophilin A (PPIA) determined as endogenous control. (b) Immunofluorescent staining 
(FITC, green fluorescence) of ARs in organ-cultured human HFs. Nuclei were counterstained 
with 4’,6-diamidino-2’-phenylindole (DAPI, blue fluorescence). Scale bars represent 50 µm. 
DP, dermal papilla; MK, matrix keratinocytes; ORS, outer root sheath. Inset: negative control 
(NC). (c) Expression of ARs’ transcripts in cultured ORS keratinocytes determined by Q- PCR 
as on panel (a). (d) Immunofluorescent staining (FITC, green fluorescence) of ARs in cultured 
human ORS keratinocytes. Scale bars represent 10 µm. Inset: negative control (NC). (e) ORS 
keratinocytes were isolated from 3 individual donors and cultured in the presence of 100 µM 
adenosine and adenosine receptor antagonist CGS15943 (CGS, 100 nM) or A2B selective 
blocker MRS1754 (MRS, 10 nM) as indicated for 3 hrs. Relative gene expression was 
determined and normalized to the expression values of the vehicle-treated (i.e. adenosine and 
inhibitor free) samples counted as 1 in each individual donor. Values of individual donors are 
presented as mean±SEM of three independent determinations. As endogenous control, the 
expression of PPIA was determined.
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 Figure 1: Adenosine enhanced HF elongation and prevented the hair growth-inhibiting and catagen-inducing 
effect of TGF-β2. 
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 Figure 2: Adenosine Receptors (ARs) expressed in isolated human hair follicles (HFs) and cultured outer root 
sheath (ORS) keratinocytes controlled the expression of negative and positive hair cycle regulators in 
isolated ORS keratinocytes. 
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2SUPPLEMENTARY METHODS
Isolation and Maintenance of Hair Follicles (HFs):
Human anagen VI HFs were isolated from the skin of male donors and maintained, as we 
have described before (Bodó et al. 2005; Telek et al. 2007; Bodó et al. 2009; Ramot et al. 2010; 
Borbíró et al. 2011; Szabó et al. 2018; Oláh et al. 2016). Briefly, isolated HFs were collected 
and maintained in Williams’ E medium (Life Technologies Corporation, Foster City, CA, USA) 
supplemented with 2 mM L-glutamine (Life Technologies), 10 ng/ml hydrocortisone, 10 mg/ml 
insulin, and antibiotics (all from Sigma- Aldrich, St. Louis, MO, USA). Culture medium was 
changed every other day, whereas treatment with various compounds was performed daily. For 
immunofluorescent staining and histomorphometry, follicles were frozen at -80 °C and further 
processed after 6 days in culture.
Culturing of Human HF-derived Outer Root Sheath Keratinocytes
Plucked human scalp HFs of several male volunteers were digested using trypsin to obtain 
outer root sheath (ORS) keratinocytes (Ramot et al. 2018). Similarly, human dermal fibroblasts 
(HDFs) were obtained from de-epidermized dermis of human skin samples using enzymatic 
digestion. ORS keratinocyte cultures were kept on feeder layer of non-proliferating HDFs 
treated with mitomycin C (Sigma-Aldrich) in a 1:3 mixture of supplemented Ham’s F12 and 
Dulbecco’s modified Eagle’s medium (both from Life Technologies) supplemented with 10% 
Fetal Clone II (HyClone, South Logan, UT, USA), 0.1 nM cholera toxin, 5 μg/ml insulin, 0.4 
μg/ml hydrocortisone, 2.43 μg/ml adenine, 2 nM triiodothyronine, 10 ng/ml epidermal growth 
factor, 1 mM ascorbyl-2-phosphate and antibiotics (all from Sigma-Aldrich) as described 
previously (Bodó et al. 2005; Borbíró et al. 2011; Ramot et al. 2018; Szabó et al. 2018; Telek 
et al. 2007).
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3Before experiments, ORS keratinocytes were harvested, and re-plated without a HDF 
feeder layer in 6-well plates (200,000 cells/well) which were previously coated with 1% 
collagen (Sigma Aldrich) and kept in serum-free medium for 24 hours before treating them with 
different compounds. 3 hours after treatment cells were harvested using TRIzol (Life 
Technologies) and then RT-qPCR were performed as described below. 
Measurement of Hair Shaft Elongation
Length measurements on individual cultured HFs were performed using a light 
microscope with an eyepiece measuring graticule. Elongation was calculated for each hair 
follicle separately, by subtracting the length measured on day 0 from the value of the relevant 
day.
Quantitative “Real-Time” PCR 
Total RNA was isolated using TRIzol reagent (Life Technologies) and digested with 
recombinant RNase-free DNase-1 (Life Technologies) according to the manufacturer’s 
protocol. After isolation, 1 μg of total RNA was reverse-transcribed into cDNA using the High 
Capacity cDNA kit (Life Technologies) following the manufacturer’s instructions. 
Quantitative real-time PCR was performed on a Stratagene Mx3005p sequence detection 
system (Agilent Technologies Inc., Santa Clara, CA, USA) by using 5’ nuclease assay. PCR 
amplification was performed using specific TaqMan primers and probes as follows; for 
adenosine A1 receptor (ADORA1, Assay ID: Hs00379752_m1); for adenosine A2A receptor 
(ADORA2A, Assay ID: Hs00169123_m1); for adenosine A2B receptor (ADORA2B, Assay ID: 
Hs00386497_m1); for adenosine A3 receptor (ADORA3, Assay ID: Hs00252933_m1); for 
transforming growth factor beta 2 (TGFB2, Assay ID: Hs00234244_m1); for epidermal growth 
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4factor (EGF, Assay ID: Hs01099999_m1); for stem cell factor (SCF/KITLG, assay ID: 
Hs00241497_m1) and for insulin-like growth factor 1 receptor (IGF1R, Assay ID: 
Hs00609566_m1) using the TaqMan Gene Expression Master Mix Protocol (Life 
Technologies). As internal control, transcripts of cyclophilin A (PPIA, Assay ID: 
Hs99999904_m1) were determined. The amount of the above mentioned transcripts was 
normalized to the expression of the internal control gene, using the ΔCt method. Briefly: the 
threshold cycle (Ct) value of the target gene was subtracted from the average Ct value of the 
control gene resulting in the ΔCt value. ΔCt was then used as a power of two, which results in 
the relative expression of a given target gene compared to the control (i.e.: 2ΔCt). All 
experiments were performed in triplicates. 
Immunolabeling of ARs
To detect the four type of ARs on isolated HFs and ORS keratinocytes, we performed 
indirect fluorescent immunolabeling. Cryosections of isolated HFs fixed with ice-cold 
ethanol:acetic acid (2:1) or acetone-fixed ORS keratinocytes grown on coverslips were first 
incubated with different primary rabbit antibodies (1:100 in DCS antibody diluent [DCS 
Innovative Diagnostik-Systeme, Hamburg, Germany] overnight, 4 °C) against A1, A2A (Abcam, 
Cambridge, UK, cat. numbers: ab124780 and ab3461, respectively), A2B and A3 (Alomone 
Labs, Jerusalem, Israel, cat. numbers: AAR-003 and AAR-004, respectively) receptors. 
Sections and coverslips were then washed with phosphate-buffered saline (PBS), followed by 
incubation with Alexa Fluor 488 dye-conjugated goat anti-rabbit IgG (Life Technologies) 
(1:500 in DCS antibody diluent, 45 min) at room temperature according to standard procedures. 
Nuclei were counterstained with 4’,-6-diamidino-2-phenylindole (DAPI) (Life Technologies) 
(1 µg/ml in distilled water, 5 min), and sections were mounted with Fluoromount-G aqueous 
medium (Southern Biotech, Birmingham, USA). Images were acquired using an Eclipse E600 
Page 52 of 66
5fluorescent microscope (Nikon, Tokyo, Japan). To verify the specificity of the antibodies used, 
paraffin embedded routine histology sections from tissues known to express different ARs were 
stained as positive controls. Human cerebral cortex served as positive control for A1 and A2A 
(Latini et al. 1996; Luan et al. 2017; Svenningsson et al. 1997), human kidney for A2B (Zhang 
et al. 2013) and human cerebellum for A3 (Haeusler et al. 2015). Following deparaffination and 
antigen retrieval (in citrate-buffer, pH 6.0, at 750 W in microwave oven for 15 min), sections 
were incubated with the above primary rabbit antibodies against human ARs, then stained with 
HRP conjugated anti-rabbit IgG (1:500) (Bio-Rad, Hercules, CA, USA). Immunoreactions 
were visualized using DAB substrate kit (Vector Labs, Burlingame, California USA) and the 
sections were counterstained by hematoxylin (Sigma-Aldrich). For all immunostainings, the 
respective primary antibodies were omitted as negative controls.
Ki-67/TUNEL Double Labeling
To simultaneously detect proliferating and apoptotic cells in the HFs, Ki-67 
immunolabeling and terminal dUTP nick end labeling (TUNEL) were performed in a double-
staining protocol, respectively (Bodó et al. 2005; Borbíró et al. 2011; Langan et al. 2015; Purba 
et al. 2016; Szabó et al. 2018; Telek et al. 2007). Cryosections were fixed in 
formalin/ethanol/acetic acid and labeled with a digoxigenin-deoxyUTP (ApopTag Fluorescein 
In Situ Apoptosis detection kit; Millipore, Billerica, MA) in presence of terminal 
deoxynucleotidyl transferase (60 min, 4 °C) according to the manufacturers protocol, followed 
by overnight incubation with a mouse anti-Ki-67 antiserum (1:20, DAKO, Carpinteria, CA) at 
4 °C. TUNEL+ cells were visualized by an anti-digoxigenin FITC-conjugated antibody 
(ApopTag kit), whereas Ki-67 was detected by an Alexa Fluor 568 dye-conjugated secondary 
antibody (Life Technologies, 1:500 at 4 °C for 45 min). Negative control stainings were 
performed by omitting terminal deoxynucleotidyl transferase and the Ki-67 antibody (data not 
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6shown). Cells positive for Ki-67 or TUNEL were counted per hair bulb (under the cross-
sectional line perpendicular for the longitudinal axis of the hair shaft and tangential to the peak 
of the dermal papilla) and were normalized to the number of nuclei (DAPI+).
Histology and Quantitative Histomorphometry
Cryosections (6 µm) of cultured HFs were fixed in acetone, air-dried, and processed for 
routine histology. Hematoxylin and eosin (HE, Sigma-Aldrich) staining was used for studying 
HF morphology and hair cycle stage (anagen and different stages of catagen) of each HF was 
assessed according to defined morphological criteria (Kloepper et al. 2010; Langan et al. 2015).
Additionally, number of DAPI+ cells in a standardized area of the dermal papilla (DP) 
stalk was counted on Ki-67/TUNEL double labeled sections to further characterize hair cycle 
quantitatively (Kloepper et al. 2010).
Statistical Analysis
If not mentioned otherwise, values are presented as mean±SEM in every group. To 
compare the mean values of multiple groups, statistical analysis was subsequently performed 
by One-way ANOVA and Dunnett or Bonferroni post hoc tests, as appropriate. Significance 
was determined as *p<0.05, **p<0.01, ***p<0.001 compared to the control and/or $ or #p<0.05, 
$$ or ##p<0.01, $$$ or ###p<0.001 compared to different treated samples as indicated. Differences 
in distribution of HFs among different hair cycle stages was compared pairwise by Fisher’s 
exact test. Origin 9.0 (OriginLab Corporation, Northampton MA, USA) and IBM SPSS 
Statistics 23.0 (IBM Corporation. Armonk, NY, USA) were used to plot the data and perform 
statistical analysis, respectively. 
Page 54 of 66
7Materials
Adenosine, CGS15943 (non-selective AR antagonist), MRS1754 (selective A2B 
antagonist) and TGF-β2 were obtained from Sigma-Aldrich.
DATA AVAILABILITY STATEMENT
Datasets related to this article are freely available upon request. Requests should be addressed 
to the corresponding author.
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8SUPPLEMENTARY TEXT: DISCUSSION OF THE POTENTIAL MOLECULAR 
MECHANISMS UNDERLYING THE REGULATION OF HAIR GROWTH BY 
ADENOSINE
The favorable action of adenosine is supported by a growing body of evidence in HF 
biology but the potential mechanism of action has not been resolved yet. To get deeper insight 
into the cellular and molecular mechanisms of how adenosine can enhance human hair growth, 
we studied the effect of adenosine in an in vitro model of human hair growth using 
microdissected and organ cultured human HFs (Langan et al. 2015; Philpott et al. 1994). In 
good accordance with the previous clinical findings, we quantitatively measured that adenosine 
enhanced the hair shaft elongation in human HF cultures isolated from Caucasian male subjects 
in vitro. As a potential underlying mechanism, we found increased intrafollicular proliferation 
and also observed that the ratio of HFs in catagen stage was decreased and more HFs showed 
morphological signs characteristic for the growing anagen phase in the adenosine treated 
cultures. These results suggested that adenosine may have a regulatory effect on hair cycle. To 
explore how adenosine can influence the hair cycle, we induced the onset of the regressive 
catagen phase by adding TGF-β2 to the culture medium. Adenosine abolished the effects of 
TGF-β2: it prevented diminished hair growth, it reversed reduced intrafollicular proliferation 
and augmented apoptosis induced by TGF-β2, as well as inhibited catagen transition and kept 
the anagen morphology of the HFs. These findings strongly support that adenosine can have a 
significant impact on hair cycle regulation. Importantly, all the above effects of adenosine were 
inhibited by the general AR antagonist CGS15943 arguing for the specific role of adenosine 
related signaling in the hair growth control.
A complex molecular interaction between mesenchymal and epithelial cells of the HFs, 
e.g. dermal papilla cells and keratinocytes of the different layers, plays a crucial role in the 
regulation of hair cycle (Schneider et al. 2009; Stenn and Paus 2001). Although Wnt/β-catenin 
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9signaling and several additional factors regulating the transition between the individual phases 
are relatively well-documented in the literature, the exact origin of the cyclic program and all 
the molecular details of the intercellular interactions are not resolved as of yet (Bernard 2012). 
Earlier studies identified several positive regulator molecules of the hair cycle which promote 
hair growth and prolong anagen phase of hair follicle cultures or upregulate melanogenesis 
linked to anagen phase, e.g. β-catenin, IGF-I, fibroblast growth factor 7/keratinocyte growth 
factor (FGF7/KGF) or stem cell factor/KIT-ligand (SCF). On the other hand, negative hair cycle 
regulators like epidermal growth factor (EGF), TGF-β1, FGF5, and interferon gamma can 
initiate catagen transition and inhibit hair shaft elongation in vitro. Importantly, the expression 
of these regulatory molecules and their receptors are widely documented in various 
mesenchymal and epithelial components of the HFs providing an extended paracrine regulatory 
network for hair cycle and growth control (Langan et al. 2015; Paus et al. 2014; Stenn and Paus 
2001). The modulation of these paracrine mechanisms regulating the hair cycle may be an 
effective tool to influence hair growth. For example, activation of β-catenin signaling activated 
a telogen to anagen transition and induced intense growth and intrafollicular proliferation of the 
epithelial components in HFs (Choi et al. 2013; Van Mater et al. 2003). Importantly, an intimate 
relationship is suggested between adenosine and Wnt/β-catenin signaling in the skin. It was 
shown that A2A promotes collagen type III synthesis via β-catenin activation in human dermal 
fibroblasts (Shaikh et al. 2016) and pharmacological blockade of A2A diminished the activity 
of Wnt/β-catenin pathway in a bleomycin-induced dermal fibrosis mouse model (Zhang et al. 
2017). Moreover, Wnt/β-catenin signaling can promote extracellular adenosine generation via 
upregulating ecto-5'-nucleotidase and downregulating adenosine deaminase in Rat-1 cell line 
(Spychala and Kitajewski 2004). These data suggest that Wnt/β-catenin pathway can be a 
downstream target of adenosine receptor signalling as well as can act as a regulator of adenosine 
production i.e upstream of adenosine receptors. Moreover, in recent studies, adenosine was 
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reported to increase the expression of FGF2, FGF7, IGF1 and VEGF in cultured dermal papilla 
fibroblasts (Hwang et al. 2012). In human dermal papilla cell cultures, the upregulation of FGF7 
by adenosine was abolished in the presence of the A2B antagonist alloxazine. In good 
accordance, A2B receptors were also detected by immunohistochemistry in the dermal papilla 
and outer root sheath of human hair follicles (Iino et al. 2007). In our study, we detected all AR 
subtypes in human cultured HFs. Importantly, our quantitative gene expression data also 
verified the A2B as the dominantly expressed AR in the HF. The expression pattern was similar 
to that found by Iino et al. (Iino et al. 2007): beyond the dermal papilla, the outer root sheath 
showed strong positivity for A2B receptors. This high expression was maintained in isolated 
outer root sheath keratinocytes in vitro, as well.
Treating the ORS keratinocyte cultures with adenosine, we revealed a marked alteration 
in the expression of hair cycle regulating factors: the receptor of the positive hair cycle regulator 
IGF1 and the anagen related pigmentation promoting SCF were upregulated, but the strong 
catagen inducer TGF-β2 and EGF were downregulated. These results suggest that the anagen 
and hair growth promoting effect of adenosine, next to the previously suggested dermal papilla 
cells, may be mediated by the outer root sheath, as well. These results suggest that adenosine 
can generally affect both sides of the local mesenchymal-epithelial paracrine communication 
in the HF.
Importantly, HFs seems not to be only “passive” targets of adenosine, but might produce 
adenosine locally, although this likely assumption still requires further experimental support. 
However, earlier results suggested that a local, intrafollicular adenosine system can mediate the 
effect of hair growth promoting drugs. Minoxidil, a well-known hair growth promoting 
compound generally used to treat alopecia (Goren and Naccarato 2018), was shown to increase 
VEGF production in dermal papilla cells which effect was mimicked by adenosine and 
attenuated by inhibitors of A1 and A2 receptors expressed by dermal papilla cells suggesting 
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that local adenosine production mediates the beneficial effect of minoxidil on hair growth (Li 
et al. 2001). Although the mechanism of the local adenosine production is not known yet, a 
recent study reported expression of connexin and pannexin channels in the keratinocytes of the 
hair follicles (Cowan et al. 2012) which channels are known to release ATP (Lazarowski 2012), 
the precursor of extracellular adenosine synthesis by ectonucelotidases ecto-apyrase (CD39) 
and ecto-5’-nucleotidase (CD73) (Zimmermann 2000). 
Although the detailed description of the intrafollicular adenosine system needs further 
studies, our results provide a deeper insight into the mechanisms on how adenosine can promote 
hair growth via increased intrafollicular proliferation and inhibition of catagen transition. 
Moreover, our findings highlighted the potential role of outer root sheath keratinocytes and 
their adenosine receptors as a target of exogenously applied or endogenously produced 
adenosine. These results underline the role of the intrafollicular adenosine signaling as a 
potential therapeutic target to treat hair loss-associated diseases.
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SUPPLEMENTARY FIGURE LEGENDS
Supplementary Figure 1. Adenosine enhanced intrafollicular proliferation and prolonged 
anagen phase in human HF organ cultures. (a) Co-immunolabeling of proliferating (Ki67+, 
red) and apoptotic (TUNEL+, green) cells along with nuclear staining (DAPI, blue). Auber’s 
line is indicated through the bulbs. Scale bars represent 50 µm. (b) Mean ratio of Ki67+ cells 
as percentage of the total cell count (DAPI+ cells) in the bulb, N=25-31 HFs/group from three 
donors, *p<0.05, between the indicated groups by One-way ANOVA and Bonfferroni post hoc 
test. (c) Representative histological (hematoxylin-eosin) images illustrating the morphological 
changes (d) Percentage of organ cultured HFs in anagen and catagen stages as determined by 
quantitative hair cycle histomorphometry based on hematoxylin eosin-stained sections. N=25-
31 HFs/group from three donors. 
Supplementary Figure 2. Adenosine prevents the effect of TGFβ2 as demonstrated by the 
decrease of  the number of cells in the DP stalk, a quantitative marker of hair cycle-
staging. (a) Representative images illustrating the region in which the number of DAPI+ nuclei 
were analyzed. In catagen stage, more DAPI+ cells migrate to the DP stalk. Scale bars represent 
50 µm. (b) Quantitative analysis on the number of cells in the DP stalk. N=17-24 HFs/group, 
**p<0.01 and ***p<0.001 comparing the indicated groups as determined by One-way ANOVA 
and Bonferroni post hoc tests (b).
Supplementary Figure 3. Specificity of the antibodies used to detect human ARs via 
immunolabaling. Various tissues described in the cited literature as expressing ARs were 
labeled with the primary antibodies used to stain ARs in HFs and ORS keratinocytes. (a) A1 
stained in human cerebral cortex. Pyr.c.,: Pyramidal cell (b) A2a stained in human cerebral 
cortex. (c) A2b stained in human kidney. gl.: glomerulus, PCT: proximal tubule, DCT: distal 
tubule. (d) A3 stained in human cerebellar cortex. mol.lay.: molecular layer, gr.lay.: granular 
layer,  Pur.c.: Purkinje cell. NC: negative control. Scale bars represent 50 µm.
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